Anadin and Advil maker narrows media review
LONDON - Wyeth, the pharmaceutical company behind painkiller Anadin, has cut the shortlist on its £5m media review to two, dropping incumbent Mediaedge:cia.
Wyeth has shortlisted BBJ and Optimedia, which was also an incumbent handling the Centrum vitamin supplement. A decision is expected next week.
The review will see Wyeth centralise its media planning and buying business, which was previously split between Optimedia and Mediaedge:cia.
Mediaedge:cia had handled the bulk of the account including Anadin, Advil, Robitussin cough remedy and Preparation H.
Wyeth's advertising account is held by Publicis, although there has been little activity since last year when it launched a £2.5m Christmas TV campaign that ran throughout the party season followed by a campaign for Centrum. A campaign for Anadin Ultra ran in the Autumn, which with the Anadin work from last year is set to run again this Christmas.
Wyeth, which was previously known as Whitehall Laboratories, specialises in the manufacture of analgesics, multivitamins and antacids.
If you have an opinion on this or any other issue raised on Brand Republic, join the debate in the Forum here.
Latest jobs Jobs web feed
- Digital Planner Buyer - £28k - Big Budgets! Ultimate Asset £26000 - £28000 per annum + Benefits, London
- Creative Thinker - Senior Planner Buyer - £35k Ultimate Asset £30000 - £35000 per annum + Benefits, London
- Senior Digital Media Planner Buyer- £30k- Independent Agency Ultimate Asset £28000 - £30000 per annum + Benefits, London
- Digital Media Planner: £28k: Top Travel Clients Ultimate Asset £25000 - £28000 per annum + Benefits, London
- Head of Membership Royal Pharmaceutical Society c. £55K, Lambeth, London (Please note we are relocating to 66-68 East Smithfield Street, E1W in 2015)
- Senior UK Category Manager McCormick Ltd Haddenham, Buckinghamshire , Aylesbury, Buckinghamshire